Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Ophthalmic solution: 30 mg/mL
Registered products in the Philippines
2 products registered with the Food and Drug Administration (FDA) Philippines list Diquafosol as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
DiquasDiquafosol sodium | 30 mg/mL (3% w/v) Ophthalmic SolutionPolyethylene bottle x 5 mL (Box of 1's) | Rx | Santen Pharmaceutical Co., Ltd.Japan | Importer: Santen Philippines Inc. | DR-XY46080 | Oct 6, 2027 | |
Diquas-SDiquafosol sodium | 30 mg/mL (3% w/v) Ophthalmic SolutionLDPE pipette in aluminum pouch x 0.4 mL (Box of 30's) | Rx | Huons Co., Ltd.Korea | Importer: Santen Philippines Inc. | DR-XY48218 | Jun 21, 2027 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .